Dokumendiregister | Terviseamet |
Viit | 11.1-2/24/11629-1 |
Registreeritud | 13.11.2024 |
Sünkroonitud | 14.11.2024 |
Liik | Sissetulev dokument |
Funktsioon | 11.1 Turustamise järgne järelevalve (post-marketing surveillance) |
Sari | 11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks |
Toimik | 11.1-2/2023 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | HAL Allergy B.V. |
Saabumis/saatmisviis | HAL Allergy B.V. |
Vastutaja | Karl Kalev Türk (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: "Driehuis, Ingelise" <[email protected]>
Sent: Wed, 19 Apr 2023 09:58:32 +0000
To: "'[email protected]'" <[email protected]>
Cc: "Koster; Annette" <[email protected]>; "'[email protected]'" <[email protected]>
Subject: import of prick test
Importance: High
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear Mr Türk,
I would like to ask you some questions regarding a diagnostic (prick test) which HAL Allergy would like to import in Estonia:
I appreciate receiving your swift answer.
Kind regards,
_________________________________________________________________________________________ |
|
|
Ingelise Driehuis |
Director Legal & Compliance Officer HQ |
|
Phone: +31 (0) 88 1959 016 | Fax:+31 (0) 88 1959 001 | Mobile: +31 (0) 6 5798 7783 |
|
HAL Allergy B.V. | J.H. Oortweg 15 | 2333 CH Leiden, The Netherlands |
|
HAL Allergy Group |
|
CEO: Alex Huybens, CCFO: Florian Rösch |
|
This e-mail and any files transmitted with it may contain confidential information, and is solely intended for the addressee. If you have received this message in error, please notify the sender immediately by e-mail or telephone and delete the e-mail and any transmitted files without reading, copying or disclosing its contents to any other person. Any unauthorized disclosure of the contents of this e-mail and any files transmitted with it to other persons is prohibited. HAL Allergy Group does not accept any liability for unauthorized disclosure of the content of this e-mail and any transmitted files to third parties, mutilations to the content, or damage resulting from the use of the content of this e-mail and any transmitted files..